The tweet was deleted by the author.
But we saved everything 🙂.
Colossal, a biotechnology company, formally launched its operations in Australia.
Ben Lamm, co-founder of Colossal, announced the appointment of Andrew Pask as the company's new Chief Biology Officer. Pask, known for his extensive expertise in developmental genetics, has been brought on board to advance Colossal's ambitious projects in de-extinction and conservation biology. According to Lamm, ''bringing Andrew onto the team represents a significant step forward in our pursuit to achieve groundbreaking scientific outcomes.'' Colossal's entrance into the Australian market and the strategic hiring of Pask underscore the company's commitment to innovative biological research.
(no output)